The Orthopaedic Device Infection Network (ODIN): Building an Evidence Base for the Treatment of Periprosthetic Joint Infection through International Collaboration
Elise R. Naufal,Marjan Wouthuyzen-Bakker,Alex Soriano,Simon W. Young,Carlos A. Higuera-Rueda,Jesse E. Otero,Yale A. Fillingham,Thomas K. Fehring,Bryan D. Springer,Cade Shadbolt,Mei Lin Tay,Craig Aboltins,Jarrad Stevens,Jonathan Darby,Yves S. Poy Lorenzo,Peter F.M. Choong,Michelle M. Dowsey,Sina Babazadeh
DOI: https://doi.org/10.1016/j.arth.2024.03.010
IF: 4.435
2024-03-14
The Journal of Arthroplasty
Abstract:Periprosthetic joint infections (PJI) are associated with substantial morbidity, affecting between 1 and 2% of patients undergoing a primary joint arthroplasty and approximately 7% of patients undergoing an aseptic joint revision [1]. Management of this condition typically requires prolonged hospital stays, multiple surgical procedures, and long-term antibiotic therapy. Such intensive management is associated with adverse mental health outcomes [2], reductions in overall quality of life [3], and high rates of morbidity [4, 5]. Despite being the focus of a growing body of clinical research, there have been few meaningful improvements in treatment outcomes for patients who had a PJI over the past two decades. Even with the best available treatment, one in six patients that contract a PJI will die within five years of diagnosis [6]. Many barriers to improving treatment outcomes stem from PJI being a relatively rare complication, which challenges any single center to create large, high-quality data. To overcome these barriers, we have established a multinational collaborative, the Orthopaedic Device Infection Network (ODIN). The overarching goal of ODIN is to improve the understanding and treatment of PJI through the development of a large scale, standardized, network of international databases and the building of the infrastructure necessary to pool and analyze this data efficiently.
orthopedics